Employees: 03 (2023.0)Legal category: SCA (commandite par actions)Size: ETICreation date: 2010-02-10 (16 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: SAINT-DENIS (97490), La Reunion
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
H.F. SCIENTIFIC TECHNOLOGIES : revenue, balance sheet and financial ratios
H.F. SCIENTIFIC TECHNOLOGIES is a French company
founded 16 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in SAINT-DENIS (97490),
this company of category ETI
shows in 2024 a net income positive of 354 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - H.F. SCIENTIFIC TECHNOLOGIES (SIREN 520167396)
Indicator
2024
2023
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
354 101 €
446 121 €
622 732 €
321 036 €
288 393 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, H.F. SCIENTIFIC TECHNOLOGIES generates positive net income of 354 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 288 k€ -> 354 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
354 101 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.473%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.753%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2023
2024
Debt ratio
1.751
1.052
0.453
4.584
0.473
Financial autonomy
48.293
54.632
56.039
65.197
74.753
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
0.472024
2021
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good
In 2024, the debt ratio of H.F. SCIENTIFIC TECHNOLOGIES (0.47) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
74.75%2024
2021
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excellent+10 pts over 3 years
In 2024, the financial autonomy of H.F. SCIENTIFIC TECHNOLOGIES (74.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 406.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2023
2024
Liquidity ratio
230.565
221.159
179.259
346.652
406.674
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
406.672024
2021
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent+35 pts over 3 years
In 2024, the liquidity ratio of H.F. SCIENTIFIC TECHNOLOGIES (406.67) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of H.F. SCIENTIFIC TECHNOLOGIES in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of H.F. SCIENTIFIC TECHNOLOGIES is estimated at
290 899 €
(range 110 718€ - 1 062 328€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
110k€290k€1062k€
290 899 €Range: 110 718€ - 1 062 328€
NAF 5 all-time
Valuation method used
Net Income Multiple
354 101 €
×
0.8x
=290 900 €
Range: 110 718€ - 1 062 328€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare H.F. SCIENTIFIC TECHNOLOGIES with other companies in the same sector:
Frequently asked questions about H.F. SCIENTIFIC TECHNOLOGIES
What is the revenue of H.F. SCIENTIFIC TECHNOLOGIES ?
The revenue of H.F. SCIENTIFIC TECHNOLOGIES is not publicly disclosed (confidential accounts filed with INPI).
Is H.F. SCIENTIFIC TECHNOLOGIES profitable?
Yes, H.F. SCIENTIFIC TECHNOLOGIES generated a net profit of 354 k€ in 2024.
Where is the headquarters of H.F. SCIENTIFIC TECHNOLOGIES ?
The headquarters of H.F. SCIENTIFIC TECHNOLOGIES is located in SAINT-DENIS (97490), in the department La Reunion.
Where to find the tax return of H.F. SCIENTIFIC TECHNOLOGIES ?
The tax return of H.F. SCIENTIFIC TECHNOLOGIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does H.F. SCIENTIFIC TECHNOLOGIES operate?
H.F. SCIENTIFIC TECHNOLOGIES operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart